Edgewise Therapeutics (NASDAQ:EWTX) was downgraded to Sector Perform from prior Sector Outperform at Scotiabank after results ...

Global Equity Research announced adjustments to its equity ratings, responding to the recent imposition of broad tariffs by the US administration. While most countries are affected by these tariffs, ...

Bank of America Securities downgraded the Bank of Nova Scotia (NYSE:BNS), known as Scotiabank, to Neutral from Buy as its ...

As previously reported, Scotiabank analyst Nick Altmann downgraded nCino (NCNO) to Sector Perform from Outperform with a price target of $19, ...

In a report released today, Ovais Habib from Scotiabank maintained a Hold rating on First Majestic Silver (AG – Research Report), with a price ...

Manufacturers don’t have enough workers as it is, and labour force growth projections are soft ...

After ending 2024 on a solid note with 20% gains, Bank of Nova Scotia ( TSX:BNS ), or Scotiabank, has turned volatile in 2025 ...

Scotiabank is pleased to announce it has been recognized in Canada on The Globe and Mail's 2025 Report on Business magazine's annual Women Lead Here list for the fifth consecutive year. This annual ...

Myriad Genetics (NASDAQ:MYGN – Get Free Report) had its target price lowered by Scotiabank from $24.00 to $20.00 in a note ...

The Canadian Dollar (CAD) is little changed—and a relative, if minor, underperformer versus many of its peers, Scotiabank's ...